Clinical Trial: A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease

U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07111013) titled 'A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease' on Aug. 06.

Brief Summary: A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane Fixed-Dose Combination in Subjects With Dry Eye Disease

Study Start Date: Dec., 2025

Study Type: INTERVENTIONAL

Condition: Dry Eye Disease

Intervention: DRUG: Lifitegrast/perfluorohexyloctane (PFHO)

fixed-dose combination (FDC) (5%/95%)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Bausch & Lomb Incorporated

Disclaimer: Curated by HT Syndication....